Editorial Comment.
作者信息
Labbate Craig V, Adibi Mehrad, Matin Surena F
机构信息
Department of Urology, MD Anderson Cancer Center, Houston, Texas.
出版信息
J Urol. 2022 Jun;207(6):1309-1310. doi: 10.1097/JU.0000000000002454.02. Epub 2022 Mar 3.
Abstract
摘要
相似文献
1
Editorial Comment.
J Urol. 2022 Jun;207(6):1309-1310. doi: 10.1097/JU.0000000000002454.02. Epub 2022 Mar 3.
2
Editorial Comment: Heterogeneity of Bone Marrow Stromal Cells Editorial Comment on Dr. Waller's Paper.编辑评论：骨髓基质细胞的异质性 对沃勒博士论文的编辑评论
Hematology. 1999;4(1):45-6. doi: 10.1080/10245332.1999.11746429.
3
Comment on Furst's Editorial: Postmarketing Surveys: Up Sides and Down Sides: In Reply to "Comment on Furst Editorial: Postmarketing Surveys, Upsides and Downsides".对弗斯特社论的评论：上市后调查：优点与缺点：回应《对弗斯特社论的评论：上市后调查，优点与缺点》
J Clin Rheumatol. 2003 Aug;9(4):280-1. doi: 10.1097/01.rhu.0000081273.16685.94.
4
Editorial comment.社论评论。
Mult Scler. 2013 May;19(6):825. doi: 10.1177/1352458513486409.
5
Comment on editorial comment of May '68: dentistry as we konw it today may be headed for extinction.对1968年5月社论评论的评论：我们如今所知的牙科可能正走向消亡。
Greater St Louis Dent Soc Bull. 1968 Jun;39(6):100-1.
6
Editorial comment: How true outcomes-based commissioning can really 'liberate' healthcare services.编辑评论：基于真实结果的委托究竟如何才能真正“解放”医疗服务。
Future Hosp J. 2015 Jun;2(2):150. doi: 10.7861/futurehosp.2-2-150.
7
Editorial: Urinary incontinence. An editorial comment.社论：尿失禁。一篇社论评论。
Obstet Gynecol. 1976 Mar;47(3):367-8.
8
Editorial comment: the future of compositional MRI for cartilage.社论评论：软骨的成分 MRI 的未来。
Eur Radiol. 2018 Jul;28(7):2872-2873. doi: 10.1007/s00330-018-5457-4. Epub 2018 Apr 30.
9
Editorial comment: Determining doctors' views on performance measurement and management of their clinical practice.编辑评论：确定医生对其临床实践的绩效评估和管理的看法。
Future Hosp J. 2015 Oct;2(3):171-172. doi: 10.7861/futurehosp.2-3-171.
10
Comment on "Editorial comment" from Masakiyo Nobuyoshi, M.D., Cathet Cardiovasc Diagn 33:156(1994).
Cathet Cardiovasc Diagn. 1995 Apr;34(4):372. doi: 10.1002/ccd.1810340225.
引用本文的文献
1
Comment on "Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report".关于“使用含丝裂霉素的反向热凝胶UGN - 101对低级上尿路尿路上皮癌进行初次化学消融治疗的反应持久性：OLYMPUS试验最终报告”的评论
World J Urol. 2022 May;40(5):1251-1252. doi: 10.1007/s00345-022-03968-7. Epub 2022 Feb 22.
Zotero 插件